Cargando…

Cardiovascular disease in SARS‐CoV‐2 infection

Pre‐existing cardiovascular disease (CVD) increases the morbidity and mortality of COVID‐19 and is strongly associated with poor disease outcomes. However, SARS‐CoV‐2 infection can also trigger de novo acute and chronic cardiovascular disease. Acute cardiac complications include arrhythmia, myocardi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Kei, Sinclair, Jane E, Sadeghirad, Habib, Fraser, John F, Short, Kirsty R, Kulasinghe, Arutha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Special Feature Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423130/ https://www.ncbi.nlm.nih.gov/pubmed/34512975 http://dx.doi.org/10.1002/cti2.1343

Ejemplares similares

The mutational spectrum of SARS-CoV-2 genomic and antigenomic RNA
por: Zhao, Lele, et al.
Publicado: (2022)

Transcriptomic profiling of cardiac tissues from SARS‐CoV‐2 patients identifies DNA damage
por: Kulasinghe, Arutha, et al.
Publicado: (2022)

Air contamination with SARS-CoV-2 in the operating room
por: Hirota, Kazuyoshi
Publicado: (2020)

Interpretation of laboratory tests for prevention of the SARS-CoV-2 transmission
por: Masui, Kenichi
Publicado: (2020)

Endothelial cells are not productively infected by SARS‐CoV‐2
por: Schimmel, Lilian, et al.
Publicado: (2021)

The pharmacist’s role in SARS-CoV-2 diagnostic testing
por: Goode, Jean-Venable R., et al.
Publicado: (2020)

Drugs acting on the renin–angiotensin system and SARS-CoV-2
por: Vitiello, Antonio, et al.
Publicado: (2021)

Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures
por: Kulasinghe, Arutha, et al.
Publicado: (2022)

Preparing for the SARS-CoV-2 pandemic: creation and implementation of new recommendations
por: Conrad, David, et al.
Publicado: (2020)

Dissecting Tissue Compartment-Specific Protein Signatures in Primary and Metastatic Oropharyngeal Squamous Cell Carcinomas
por: Sadeghirad, Habib, et al.
Publicado: (2022)

Partial COVID-19 vaccination associated with reduction in postoperative mortality and SARS-CoV-2 infection
por: Prasad, Nikhil K., et al.
Publicado: (2022)

Tocilizumab in patients infected by SARS-CoV2()
por: Sancho, Milagros, et al.
Publicado: (2021)

The interplay of SARS-CoV-2 and Clostridioides difficile infection
por: Khanna, Sahil, et al.
Publicado: (2021)

Promoting scientific collaboration and education in cardiovascular–renal medicine: EURECAM: An ERA-EDTA-based working group
por: Covic, Adrian, et al.
Publicado: (2009)

SARS-CoV-2 antibody testing—questions to be asked
por: Özçürümez, Mustafa K., et al.
Publicado: (2020)

SARS-CoV-2 Vaccines: Where Are We Now?
por: Flanagan, Katie L., et al.
Publicado: (2021)

SARS-CoV-2 and Chlamydia pneumoniae co-infection: A review of the literature
por: Frutos, María Celia, et al.
Publicado: (2022)

Assessing the potential for fomite transmission of SARS-CoV-2
por: Short, Kirsty R, et al.
Publicado: (2023)

Endemic and Emerging Coronavirus Pulmonary Infections
por: Flamenbaum, Matthew, et al.
Publicado: (2020)

Genomic communication via circulating extracellular vesicles and long-term health consequences of COVID-19
por: Nair, Soumyalekshmi, et al.
Publicado: (2023)

Inflammation, malnutrition, and SARS-CoV-2 infection: A disastrous combination()
por: Carretero Gómez, J., et al.
Publicado: (2020)

Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection
por: Tan, Jie, et al.
Publicado: (2020)

Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?
por: El-Qutob, D., et al.
Publicado: (2022)

Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?
por: El-Qutob, D., et al.
Publicado: (2022)

SARS-CoV-2 Variants and Vaccines
por: Krause, Philip R., et al.
Publicado: (2021)

Sexual conflict in twins: male co-twins reduce fitness of female Soay sheep
por: Korsten, Peter, et al.
Publicado: (2009)

Activities and Health Status of Dispatched Public Health Nurses after the Great East Japan Earthquake
por: Yokoyama, Yoshie, et al.
Publicado: (2014)

Immune Checkpoint Inhibitors in Cancer Therapy
por: Shiravand, Yavar, et al.
Publicado: (2022)

Bioinformatical study on the proteomics and evolution of SARS-CoV
por: Liu, Shuqun, et al.
Publicado: (2003)

Therapeutische Nanobodies gegen SARS-CoV-2
por: Güttler, Thomas, et al.
Publicado: (2022)

Utilization of the healthcare system by gynecologic oncology patients during the SARS-CoV-2 pandemic surge in New York City
por: Gabor, Lisa, et al.
Publicado: (2021)

Diagnosis, prevention and treatment of haemodialysis catheter-related bloodstream infections (CRBSI): a position statement of European Renal Best Practice (ERBP)
por: Vanholder, Raymond, et al.
Publicado: (2010)

The potential association between PARP14 and the SARS-CoV-2 infection (COVID-19)
por: Tauber, Amanda L, et al.
Publicado: (2021)

(18)F-FDG-PET/CT in SARS-CoV-2 infection and its sequelae()
por: Rodríguez-Alfonso, B., et al.
Publicado: (2021)

Are hemoglobin-derived peptides involved in the neuropsychiatric symptoms caused by SARS-CoV-2 infection?
por: Mendonça, Michelle Mendanha, et al.
Publicado: (2022)

Cardiovascular considerations for anesthesiologists during the COVID-19 pandemic
por: Hirata, Naoyuki, et al.
Publicado: (2020)

Control of SARS-CoV-2 transmission in orthodontic practice
por: Guo, Yongwen, et al.
Publicado: (2020)

Somatic GPR101 Duplication Causing X-Linked Acrogigantism (XLAG)—Diagnosis and Management
por: Rodd, Celia, et al.
Publicado: (2016)

Adverse Events and Safety of SARS-CoV-2 Vaccines: What’s New and What’s Next
por: Corey, Kristen B., et al.
Publicado: (2022)

Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection
por: Vohra, Manik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qig4d2npb4vk090gogc500teik